Distinct beta-arrestin coupling and intracellular trafficking of metabotropic glutamate receptor homo- and heterodimers.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
08 12 2023
Historique:
medline: 11 12 2023
pubmed: 6 12 2023
entrez: 6 12 2023
Statut: ppublish

Résumé

The metabotropic glutamate receptors (mGluRs) are family C, dimeric G protein-coupled receptors (GPCRs), which play critical roles in synaptic transmission. Despite an increasing appreciation of the molecular diversity of this family, how distinct mGluR subtypes are regulated remains poorly understood. We reveal that different group II/III mGluR subtypes show markedly different beta-arrestin (β-arr) coupling and endocytic trafficking. While mGluR2 is resistant to internalization and mGluR3 shows transient β-arr coupling, which enables endocytosis and recycling, mGluR8 and β-arr form stable complexes, which leads to efficient lysosomal targeting and degradation. Using chimeras and mutagenesis, we pinpoint carboxyl-terminal domain regions that control β-arr coupling and trafficking, including the identification of an mGluR8 splice variant with impaired internalization. We then use a battery of high-resolution fluorescence assays to find that heterodimerization further expands the diversity of mGluR regulation. Together, this work provides insight into the relationship between GPCR/β-arr complex formation and trafficking while revealing diversity and intricacy in the regulation of mGluRs.

Identifiants

pubmed: 38055809
doi: 10.1126/sciadv.adi8076
pmc: PMC10699790
doi:

Substances chimiques

beta-Arrestins 0
Receptors, Metabotropic Glutamate 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadi8076

Subventions

Organisme : NIGMS NIH HHS
ID : F32 GM148001
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS129904
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM124731
Pays : United States

Références

J Exp Med. 2021 May 3;218(5):
pubmed: 33661276
Mol Cell. 2023 Jun 15;83(12):2108-2121.e7
pubmed: 37244255
Sci Adv. 2022 Nov 25;8(47):eabq3363
pubmed: 36427324
Eur J Neurosci. 1998 Dec;10(12):3629-41
pubmed: 9875342
FASEB J. 2011 Jan;25(1):66-77
pubmed: 20826542
Commun Biol. 2023 Jan 27;6(1):104
pubmed: 36707695
Neuron. 2018 Jun 27;98(6):1080-1098
pubmed: 29953871
J Biol Chem. 2001 Jun 1;276(22):19452-60
pubmed: 11279203
J Neurosci. 2014 Jan 1;34(1):79-94
pubmed: 24381270
J Neurosci. 1997 Oct 1;17(19):7503-22
pubmed: 9295396
Annu Rev Biochem. 2021 Jun 20;90:709-737
pubmed: 33606955
Annu Rev Pharmacol Toxicol. 2008;48:601-29
pubmed: 17995450
Mol Pharmacol. 1997 Jan;51(1):119-25
pubmed: 9016353
J Biol Chem. 1999 Nov 5;274(45):32248-57
pubmed: 10542263
J Biol Chem. 2000 Apr 14;275(15):11130-40
pubmed: 10753919
Cell Rep. 2021 Apr 27;35(4):109050
pubmed: 33910009
Mol Pharmacol. 2022 May;101(5):275-285
pubmed: 35246479
Elife. 2017 Jun 29;6:
pubmed: 28661401
Neuropharmacology. 2011 Jun;60(7-8):1017-41
pubmed: 21036182
Mol Biol Cell. 2015 Dec 15;26(25):4660-73
pubmed: 26490116
Neuron. 2016 Oct 5;92(1):143-159
pubmed: 27641494
Neuron. 2009 Jun 25;62(6):839-49
pubmed: 19555652
J Biol Chem. 2022 Oct;298(10):102458
pubmed: 36063995
Elife. 2019 Aug 02;8:
pubmed: 31373553
J Cell Biol. 1999 Jan 11;144(1):31-43
pubmed: 9885242
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16342-7
pubmed: 22988116
Nat Commun. 2021 Dec 9;12(1):7158
pubmed: 34887409
Neuropharmacology. 2007 Feb;52(2):253-62
pubmed: 17113112
J Biol Chem. 1999 Apr 16;274(16):10999-1006
pubmed: 10196181
FASEB J. 2008 Jul;22(7):2311-22
pubmed: 18267983
Neuron. 2020 Feb 19;105(4):663-677.e8
pubmed: 31837915
Annu Rev Pharmacol Toxicol. 2010;50:295-322
pubmed: 20055706
PLoS One. 2011 Feb 22;6(2):e17361
pubmed: 21364942
Neuropharmacology. 2021 Jun 1;190:108426
pubmed: 33279506
J Biol Chem. 2003 Nov 14;278(46):45954-9
pubmed: 12960162
Nat Commun. 2019 Dec 5;10(1):5572
pubmed: 31804469
J Biol Chem. 1999 Jan 22;274(4):2216-24
pubmed: 9890984
Neuropharmacology. 2021 Dec 1;200:108799
pubmed: 34592242
Elife. 2017 Aug 10;6:
pubmed: 28829739
Nat Commun. 2017 Dec 6;8(1):1967
pubmed: 29213077
Nat Methods. 2007 Apr;4(4):319-21
pubmed: 17369835
Cell Rep. 2020 May 5;31(5):107605
pubmed: 32375054
Mol Pharmacol. 1998 Mar;53(3):377-84
pubmed: 9495801
Chem Sci. 2020 Jul 7;11(30):7871-7883
pubmed: 34123074
J Neurosci Res. 2008 Jan;86(1):1-10
pubmed: 17663464
Elife. 2014 Sep 17;3:e03970
pubmed: 25232658
Nat Commun. 2015 Sep 08;6:8202
pubmed: 26347956
Cell Chem Biol. 2021 Nov 18;28(11):1648-1663.e16
pubmed: 33735619
Behav Brain Res. 2010 Oct 15;212(2):168-73
pubmed: 20385173
Mol Cell Neurosci. 2018 Sep;91:10-24
pubmed: 29604330
J Biol Chem. 1992 Feb 15;267(5):3530-8
pubmed: 1371121
Org Biomol Chem. 2022 Aug 3;20(30):5967-5980
pubmed: 35188523
Neuron. 2018 Jun 6;98(5):963-976.e5
pubmed: 29754753
Mol Endocrinol. 2000 Dec;14(12):2040-53
pubmed: 11117533
Life Sci. 1998;62(17-18):1561-5
pubmed: 9585136
J Biol Chem. 1997 Dec 12;272(50):31553-60
pubmed: 9395492
Behav Brain Res. 2010 May 1;209(1):21-6
pubmed: 20080129
Curr Opin Pharmacol. 2018 Feb;38:37-42
pubmed: 29494817
Front Immunol. 2023 Feb 01;14:1123841
pubmed: 36817470
Proc Natl Acad Sci U S A. 2021 Aug 17;118(33):
pubmed: 34385321
Cell. 2017 Jul 27;170(3):457-469.e13
pubmed: 28753425
Nat Rev Mol Cell Biol. 2004 Feb;5(2):121-32
pubmed: 15040445
Elife. 2021 Apr 21;10:
pubmed: 33880992
Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9909-14
pubmed: 10449793
Proc Natl Acad Sci U S A. 2004 May 4;101(18):7082-7
pubmed: 15105445
Nat Methods. 2021 Apr;18(4):397-405
pubmed: 33686301
Science. 2002 Jul 26;297(5581):615-20
pubmed: 12142540
Mol Pharmacol. 2015 Aug;88(2):347-56
pubmed: 26013542
Mol Pharmacol. 2012 Sep;82(3):438-47
pubmed: 22653971
Trends Biochem Sci. 2020 Dec;45(12):1049-1064
pubmed: 32861513
Neuropharmacology. 2021 Nov 1;199:108801
pubmed: 34547332
Eur J Neurosci. 2005 Jul;22(2):425-36
pubmed: 16045496
Nat Chem Biol. 2022 Aug;18(8):894-903
pubmed: 35681029
Pharmacol Ther. 2022 Nov;239:108275
pubmed: 36038019
Sci Rep. 2018 Oct 25;8(1):15764
pubmed: 30361629
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9241-6
pubmed: 8799185
Cell. 2022 Nov 23;185(24):4560-4573.e19
pubmed: 36368322
Sci Adv. 2020 Apr 15;6(16):eaay7193
pubmed: 32494600
J Biol Chem. 2003 Nov 14;278(46):45978-86
pubmed: 12939277
J Cell Sci. 1999 Feb;112 ( Pt 3):329-38
pubmed: 9885286
J Neurosci. 2014 Mar 26;34(13):4589-98
pubmed: 24672004
Neuropharmacology. 2008 Apr;54(5):804-14
pubmed: 18255102
Curr Opin Pharmacol. 2012 Feb;12(1):28-34
pubmed: 22040745
Neuropsychopharmacology. 2011 Jul;36(8):1599-607
pubmed: 21451497
J Biol Chem. 2000 Jun 2;275(22):17201-10
pubmed: 10748214
J Biol Chem. 1997 Dec 5;272(49):31051-7
pubmed: 9388255
Int J Mol Sci. 2020 Nov 09;21(21):
pubmed: 33182425
Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9691-6
pubmed: 16766653
Nat Genet. 2011 Sep 25;43(11):1119-26
pubmed: 21946352
Neuropharmacology. 2008 Sep;55(4):537-45
pubmed: 18533199
ACS Pharmacol Transl Sci. 2020 Mar 17;3(2):345-360
pubmed: 32296773
Elife. 2022 Nov 15;11:
pubmed: 36377786
Trends Biochem Sci. 2021 Apr;46(4):315-328
pubmed: 33127216
Cell. 2020 Dec 23;183(7):1813-1825.e18
pubmed: 33296703
Nature. 2021 Jun;594(7864):589-593
pubmed: 34135509
J Biol Chem. 2001 Dec 7;276(49):45509-12
pubmed: 11641392
Mol Biol Cell. 2022 Jul 1;33(8):ar66
pubmed: 35511883

Auteurs

Joon Lee (J)

Department of Biochemistry, Weill Cornell Medicine, New York, NY 10065, USA.

Alberto J Gonzalez-Hernandez (AJ)

Department of Biochemistry, Weill Cornell Medicine, New York, NY 10065, USA.

Melanie Kristt (M)

Department of Biochemistry, Weill Cornell Medicine, New York, NY 10065, USA.

Nohely Abreu (N)

Department of Biochemistry, Weill Cornell Medicine, New York, NY 10065, USA.

Kilian Roßmann (K)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie, 13125 Berlin, Germany.

Anisul Arefin (A)

Department of Biochemistry, Weill Cornell Medicine, New York, NY 10065, USA.

Dagan C Marx (DC)

Department of Biochemistry, Weill Cornell Medicine, New York, NY 10065, USA.

Johannes Broichhagen (J)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie, 13125 Berlin, Germany.

Joshua Levitz (J)

Department of Biochemistry, Weill Cornell Medicine, New York, NY 10065, USA.
Department of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.

Articles similaires

Engineered red Opto-mGluR6 Opsins, a red-shifted optogenetic excitation tool, an in vitro study.

Hoda Shamsnajafabadi, Zahra-Soheila Soheili, Mehdi Sadeghi et al.
1.00
Humans Optogenetics HEK293 Cells Opsins Protein Engineering
1.00
Receptors, Metabotropic Glutamate Humans HEK293 Cells Protein Multimerization Allosteric Regulation
Receptors, Dopamine D3 Phosphorylation Signal Transduction Humans Molecular Dynamics Simulation
Cryoelectron Microscopy Receptors, Opioid, delta Humans Animals Drug Discovery

Classifications MeSH